From: Perioperative statin medication impairs pulmonary outcome after abdomino-thoracic esophagectomy
Variable | All patients | Propensity score-matched patients | ||||
---|---|---|---|---|---|---|
Statin ( −) patients (n = 91) | Statin ( +) patients (n = 26) | p value | psmStatin ( −) patients (n = 52) | psmStatin ( +) patients (n = 26) | p value | |
PO hospital stay | ||||||
Total [d]a | 17 (9–141) | 25 (11–75) | 0.0068 | 16.5 (9–141) | 25 (11–75) | 0.0185 |
Initial PO stay on ICU [d]a | 4 (1–76) | 6 (2–58) | 0.0729 | 5 (1–76) | 6 (2–58) | 0.2556 |
Return to ICU [n patients] | 17 (18.7%) | 3 (11.5%) | 0.5578 | 8 (15.4%) | 3 (11.5%) | 0.7429 |
Cumulative PO stay on ICU [d]a | 5 (1–84) | 11.5 (2–58) | 0.0221 | 5 (1–84) | 11.5 (2–58) | 0.0612 |
Initial postoperative extubation [h] | 0 (0–11) | 0 (0–4) | 0.8171 | 0 (0–11) | 0 (0–4) | 0.8666 |
Cumulative perioperative mechanical ventilation [h] | 12.6 (4.8–2280) | 13.5 (5.2–788.3) | 0.5184 | 12.7 (5.3–876.9) | 13.5 (5.2–788.3) | 0.6146 |
Pneumoniab | 30 (33.0%) | 17 (65.4%) | 0.0057 | 20 (38.5%) | 17 (65.4%) | 0.0317 |
Pneumonia diagnosis on POD | 6 (1–25) | 4 (1–18) | 0.1390 | 6 (1–25) | 4 (1–18) | 0.2507 |
Tracheotomy | 13 (14.3%) | 7 (26.9%) | 0.1462 | 10 (19.2%) | 7 (26.9%) | 0.5619 |
Extubation in the operating room | 22 (24.2%) | 6 (23.1%) | 1 | 12 (23.1%) | 6 (23.1%) | 1 |
Initial extubation during the first 12 h postoperatively | 75 (82.4%) | 21 (80.8%) | 0.7808 | 42 (80.8%) | 21 (80.8%) | 1 |
Re-intubationc | 22 (24.2%) | 10 (38.5%) | 0.2111 | 15 (28.9%) | 10 (38.5%) | 0.4453 |
Perioperative oxygenation index < 300 mm Hg [n patients]d | ||||||
First intraoperative | 21 (23.1%) | 6 (23.1%) | 1 | 14 (26.9%) | 6 | 0.7891 |
POD 0 (on arrival at ICU) | 32 (35.2%) | 8 (30.8%) | 0.3429 | 22 (42.3%) | 8 | 0.4594 |
POD 1 | 27 (29.7%) | 10 (38.5%) | 0.4743 | 19 (36.5%) | 10 | 1 |
POD 2 | 37 (40.7%) | 14 (53.9%) | 0.2667 | 20 (38.5%) | 14 | 0.2312 |
POD 3 | 28 (30.8%) | 14 (53.9%) | 0.0382 | 17 (32.7%) | 14 | 0.0889 |
POD 4 | 19* (21.1%) | 12 (46.2%) | 0.0215 | 10* (19.6%) | 12 | 0.0187 |
POD 5 | 17* (18.9%) | 10 (38.5%) | 0.0624 | 11* (21.6%) | 10 | 0.1752 |
POD 6 | 21* (23.3%) | 7* (28.0%) | 0.6087 | 12* (23.5%) | 7* | 0.7795 |
POD 7 | 19* (21.1%) | 10* (40.0%) | 0.0695 | 14* (27.5%) | 10* | 0.3015 |
POD 8 | 20* (22.2%) | 10* (40.0%) | 0.1201 | 12* (23.5%) | 10* | 0.1799 |
POD 9 | 19* (21.1%) | 7* (28.0%) | 0.5890 | 12* (23.5%) | 7* | 0.7795 |
POD 10 | 17* (18.9%) | 7** (29.2%) | 0.2730 | 10* (19.6%) | 7** | 0.3860 |
Re-do (revision) surgery during POD 1–30 | 12 (13.2%) | 9 (34.6%) | 0.2278 | 10 (19.2%) | 6 (34.6%) | 0.7690 |
Anastomotic complicationse | 18 (19.8%) | 6 (23.1%) | 0.7842 | 11 (21.2%) | 6 (23.1%) | 1 |
PO 30-day mortality [n] | 6 (6.6%) | 3 (11.5%) | 0.4139 | 5 (9.6%) | 3 (11.5%) | 1 |